Company: ABUS
Filing Date: 2025-05-07
Form Type: 8-K
Source: 0001171843-25-002841
Chunk: 0

Company: Arbutus Biopharma Corp
Filing Date: 2025-05-07
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01. Other Events.

On May 7, 2025, Arbutus Biopharma Corporation (the “ Company”) issued a press release announcing the presentation of five posters, including one late-breaker, highlighting imdusiran, its RNAi therapeutic and AB-101, its oral PD-L1 inhibitor, at the European Association for the Study of the Liver (EASL) Congress 2025. A copy of the press release is filed herewith as Exhibit 99.1 and is incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit Number      Description                                                                  
            99.1      Press Release dated May 7, 2025                                              
 ───────────────────────────────────────────────────────────────────────────────────────────────────
             104      Cover Page Interactive Data File (embedded within the Inline XBRL document)